AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Vysis Inc of Downers Grove, IL has given Abbott Laboratories of Abbott Park, IL, distribution rights to its 2 genomic tests for breast and bladder cancer.
Abbott will be the exclusive distributor in North America and Europe of the DNA-based tests PathVysion HER-2 assay and the UroVysion assay.
PathVysion HER-2 assay detects and quantify the HER-2 gene in breast cancer patients, while UroVysion assay is for the detection of genetic changes in the urine's bladder cancer cells.
Both tests …